INTRODUCTION Psoriasis (PS) is a common but complex chronic inflammatory skin disease. It is characterized by red, scaly plaques, which commonly present on the extensor surfaces of the body. Psoriasis…

INTRODUCTION Since the 2000’s, an interesting dichotomy has emerged in the management of patients with moderate-to-severe psoriasis. Results from clinical trials of biologics demonstrate that clear or nearly clear skin…

INTRODUCTION Actinic keratoses (AKs) are common epidermal lesions that usually manifest clinically as red, brown, or skin-colored, rough papules or plaques on sun-exposed skin sites.1,2 The presence of multiple AKs…

INTRODUCTION Psoriatic arthritis (PsA) is a seronegative spondyloarthropathy characterized by musculoskeletal signs and symptoms (arthritis, enthesitis, spondylitis) with associated joint pain and tenderness.1 It affects an estimated 0.3% to 1.0%…

INTRODUCTION Plaque psoriasis is a chronic, inflammatory disease of the skin characterized by a wide array of symptoms such as scaling, itching, redness, and pain.1-3 A survey of 10,676 adults…

INTRODUCTION Rosacea is a common and chronic skin disorder affecting an estimated 16 million people in the United States.1 Rosacea primarily affects the central facial area (ie, cheeks, nose, chin,…

INTRODUCTION The elderly represent a significant proportion of psoriasis vulgaris patients due to the chronic nature of the disease and its bimodal incidence with a second peak near the seventh…

INTRODUCTION Onychomycosis is a common fungal infection of the toenails or fingernails, representing around half of all nail diseases, and affecting 10%-20% of adults, particularly the elderly where the prevalence…

INTRODUCTION It is estimated that approximately 7.4 million adults in the United States are affected by psoriasis.1 Adalimumab, a tumor necrosis factor (TNF) inhibitor, has been approved for the treatment…

INTRODUCTION Onychomycosis is the most common nail disease in adults, representing up to 50% of all nail disorders, nearly always being associated with tinea pedis.1-3 Epidemiologic data indicate a prevalence…

INTRODUCTION Tumor necrosis factor (TNF)-α inhibitors are the mainstay in treating multiple immune-mediated diseases. In 2008, the American Academy of Dermatology (AAD) working group recommended TNF-α inhibitor avoidance in patients…

INTRODUCTION The exact incidence of pediatric psoriasis is unknown. However, an estimated 31% to 45% of psoriasis patients have disease onset before the age of 16 years.1 As in adults,…